Winton Capital Management’s Zimmer Biomet ZBH Stock Holding History

Winton Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	$50.6M	Buy	550,732 +167,059	+44%	+$15.4M	0.35%	101
2013 Q4	$34.7M	Buy	383,673 +141,908	+59%	+$12.3M	0.31%	118
2013 Q3	$19.3M	Sell	241,765 -129,794	-35%	-$10.2M	0.23%	165
2013 Q2	$27M	Buy	+371,559	New	+$27.8M	0.33%	124

Other funds holding ZBH

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

IFP

Independent Franchise Partners London, United Kingdom $15.2B AUM 1.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $70.2B AUM 30.95% 1-Year Est. Return

Winton Capital Management's ZBH Position: Q1 2014 in Review

Winton Capital Management increased its Zimmer Biomet (ZBH) stake by 44% in Q1 2014, buying an estimated $15.4M and bringing the position to 550,732 shares worth $50.6M. The position accounts for 0.35% of the portfolio, ranked #101.

Winton Capital Management first reported a position in ZBH in Q2 2013 and has held it in 4 quarters since. 706 funds tracked by Wall St. Rank hold ZBH as of Q1 2014.

Winton Capital Management held 550,732 shares of Zimmer Biomet worth $50.6M as of Q1 2014.
Winton Capital Management bought 167,059 Zimmer Biomet shares in Q1 2014, an estimated $15.4M.
Zimmer Biomet made up 0.35% of Winton Capital Management's portfolio in Q1 2014, its #101 holding.
Winton Capital Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 4 quarters since.
706 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2014.

Based on Winton Capital Management's 13F filing for Q1 2014, filed 1 May 2014.